Nkarta(NKTX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

NKTX Nkarta

盘前交易 07-22 07:27:28 EDT

6.21

-0.44

-6.62%

最高6.68	最低6.14	成交量74.58万
今开6.68	昨收6.65	日振幅8.20%
总市值4.38亿	流通市值1.98亿	总股本7,047万
成交额473.62万	换手率2.34%	流通股本3,191万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"NKTX","market":"US","secType":"STK","nameCN":"Nkarta","latestPrice":6.21,"timestamp":1721419200000,"preClose":6.65,"halted":0,"volume":745759,"delay":0,"floatShares":31905863,"shares":70467620,"eps":-2.349711,"marketStatus":"盘前交易","marketStatusCode":1,"change":-0.44,"latestTime":"07-22 07:27:28 EDT","open":6.68,"high":6.68,"low":6.135,"amount":4736171.477512999,"amplitude":0.081955,"askPrice":7.05,"askSize":100,"bidPrice":6,"bidSize":50,"shortable":3,"etf":0,"ttmEps":-2.349711,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721655000000},"adr":0,"listingDate":1594353600000,"adjPreClose":6.21,"postHourTrading":{"tag":"盘后","latestPrice":6.22,"preClose":6.21,"latestTime":"18:50 EDT","volume":1629,"amount":10170.8037,"timestamp":1721429403307},"volumeRatio":0.5522338750792464,"impliedVol":1.3123,"impliedVolPercentile":0.356},"requestUrl":"/m/hq/s/NKTX/tweets","defaultTab":"tweets","newsList":[{"id":"2452407001","title":"Nkarta, Inc.盘中异动 大幅下挫5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452407001","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452407001?lang=zh_cn&edition=full","pubTime":"2024-07-20 02:43","pubTimestamp":1721414600,"startTime":"0","endTime":"0","summary":"北京时间2024年07月20日02时43分，Nkarta, Inc.股票出现波动，股价快速跳水5.11%。Nkarta, Inc.股票所在的生物技术行业中，整体跌幅为0.23%。其相关个股中，Exicure, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、60 Degrees Pharmaceuticals, Inc.涨幅较大，60 Degrees Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.、Silo Pharma, Inc.较为活跃，换手率分别为1728.21%、1654.39%、307.52%，振幅较大的相关个股有Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、60 Degrees Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.，振幅分别为173.51%、104.07%、82.80%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407200243209681e974&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407200243209681e974&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NKTX","BK4505"],"gpt_icon":0},{"id":"2452812294","title":"Nkarta, Inc.盘中异动 早盘股价大跌5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452812294","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452812294?lang=zh_cn&edition=full","pubTime":"2024-07-18 21:31","pubTimestamp":1721309471,"startTime":"0","endTime":"0","summary":"北京时间2024年07月18日21时31分，Nkarta, Inc.股票出现异动，股价快速下挫5.29%。Nkarta, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。其相关个股中，Onconetix, Inc.、Nkgen Biotech, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 涨幅较大，Onconetix, Inc.、Bionomics Ltd Ads Each Rep 180 Ord Shs、Salarius Pharmaceuticals, Inc.较为活跃，换手率分别为215.58%、123.21%、107.88%，振幅较大的相关个股有Onconetix, Inc.、Inventiva Sa、Nkgen Biotech, Inc.，振幅分别为15.70%、9.60%、8.55%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718213111941f8525&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718213111941f8525&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTX","BK4505","BK4139"],"gpt_icon":0},{"id":"2452165670","title":"Nkarta, Inc.盘中异动 早盘股价大跌5.00%报7.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452165670","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452165670?lang=zh_cn&edition=full","pubTime":"2024-07-17 22:57","pubTimestamp":1721228273,"startTime":"0","endTime":"0","summary":"北京时间2024年07月17日22时57分，Nkarta, Inc.股票出现异动，股价急速下挫5.00%。截至发稿，该股报7.60美元/股，成交量28.7623万股，换手率0.41%，振幅4.87%。Nkarta, Inc.股票所在的生物技术行业中，整体跌幅为2.25%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717225753941f7f06&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717225753941f7f06&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NKTX","BK4505"],"gpt_icon":0},{"id":"2451891881","title":"Nkarta, Inc.盘中异动 股价大涨5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2451891881","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451891881?lang=zh_cn&edition=full","pubTime":"2024-07-16 21:49","pubTimestamp":1721137747,"startTime":"0","endTime":"0","summary":"北京时间2024年07月16日21时49分，Nkarta, Inc.股票出现波动，股价急速上涨5.13%。Nkarta, Inc.股票所在的生物技术行业中，整体涨幅为0.53%。其相关个股中，Silo Pharma, Inc.、Scisparc Ltd.、Conduit Pharmaceuticals Inc.涨幅较大，Silo Pharma, Inc.、Scisparc Ltd.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为1634.70%、833.49%、89.51%，振幅较大的相关个股有Scisparc Ltd.、Aeon Biopharma, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为40.48%、36.40%、36.00%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407162149089681d31a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407162149089681d31a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTX","BK4505","BK4139"],"gpt_icon":0},{"id":"2451667623","title":"Nkarta, Inc.盘中异动 早盘大幅拉升5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2451667623","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451667623?lang=zh_cn&edition=full","pubTime":"2024-07-15 21:39","pubTimestamp":1721050750,"startTime":"0","endTime":"0","summary":"北京时间2024年07月15日21时39分，Nkarta, Inc.股票出现异动，股价大幅拉升5.07%。Nkarta, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。其相关个股中，Aeon Biopharma, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Solid Biosciences Inc.涨幅较大，Artelo Biosciences, Inc.、Qualigen Therapeutics, Inc.、Enveric Biosciences, Inc.较为活跃，换手率分别为95.92%、53.47%、23.86%，振幅较大的相关个股有Aeon Biopharma, Inc.、Enveric Biosciences, Inc.、Humacyte Inc C/Wts 27/08/2026 ，振幅分别为29.64%、18.40%、12.78%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715213910941f70db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715213910941f70db&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTX","BK4505","BK4139"],"gpt_icon":0},{"id":"2450535913","title":"Nkarta, Inc.盘中异动 早盘股价大涨5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450535913","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450535913?lang=zh_cn&edition=full","pubTime":"2024-07-12 21:46","pubTimestamp":1720791997,"startTime":"0","endTime":"0","summary":"北京时间2024年07月12日21时46分，Nkarta, Inc.股票出现异动，股价快速上涨5.26%。截至发稿，该股报6.81美元/股，成交量16.2195万股，换手率0.23%，振幅6.03%。Nkarta, Inc.股票所在的生物技术行业中，整体涨幅为1.16%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712214638af921d5d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712214638af921d5d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTX","BK4139","BK4505"],"gpt_icon":0},{"id":"2450935002","title":"Nkarta, Inc.盘中异动 早盘急速上涨5.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450935002","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450935002?lang=zh_cn&edition=full","pubTime":"2024-07-11 21:31","pubTimestamp":1720704707,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日21时31分，Nkarta, Inc.股票出现异动，股价快速上涨5.47%。Nkarta, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。其相关个股中，Biodexa Pharmaceuticals Plc、Kazia Therapeutics Limited、Cns Pharmaceuticals, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Salarius Pharmaceuticals, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为331.71%、260.45%、175.42%，振幅较大的相关个股有Biodexa Pharmaceuticals Plc、Kazia Therapeutics Limited、Virpax Pharmaceuticals, Inc.，振幅分别为30.94%、25.44%、15.88%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711213147941f641d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711213147941f641d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTX","BK4139","BK4505"],"gpt_icon":0},{"id":"2450816402","title":"Nkarta, Inc.盘中异动 股价大跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450816402","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450816402?lang=zh_cn&edition=full","pubTime":"2024-07-10 22:19","pubTimestamp":1720621192,"startTime":"0","endTime":"0","summary":"北京时间2024年07月10日22时19分，Nkarta, Inc.股票出现异动，股价大幅跳水5.07%。截至发稿，该股报5.43美元/股，成交量10.3275万股，换手率0.15%，振幅5.07%。Nkarta, Inc.股票所在的生物技术行业中，整体涨幅为0.35%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407102219539681b8ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407102219539681b8ed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","NKTX","BK4139"],"gpt_icon":0},{"id":"2450078540","title":"Nkarta, Inc.盘中异动 股价大涨5.09%报5.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450078540","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450078540?lang=zh_cn&edition=full","pubTime":"2024-07-10 00:40","pubTimestamp":1720543215,"startTime":"0","endTime":"0","summary":"北京时间2024年07月10日00时40分，Nkarta, Inc.股票出现波动，股价快速拉升5.09%。截至发稿，该股报5.57美元/股，成交量13.88万股，换手率0.20%，振幅7.55%。Nkarta, Inc.股票所在的生物技术行业中，整体跌幅为0.30%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407100040159681b31f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407100040159681b31f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","NKTX","BK4139"],"gpt_icon":0},{"id":"2449270342","title":"Nkarta, Inc.盘中异动 快速上涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449270342","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449270342?lang=zh_cn&edition=full","pubTime":"2024-07-08 21:34","pubTimestamp":1720445696,"startTime":"0","endTime":"0","summary":"北京时间2024年07月08日21时34分，Nkarta, Inc.股票出现波动，股价快速拉升5.02%。截至发稿，该股报5.44美元/股，成交量1.1572万股，换手率0.02%，振幅3.09%。Nkarta, Inc.股票所在的生物技术行业中，整体涨幅为0.16%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708213456af9115f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708213456af9115f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTX","BK4505","BK4139"],"gpt_icon":0},{"id":"2448893844","title":"Nkarta, Inc.盘中异动 股价大涨5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448893844","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448893844?lang=zh_cn&edition=full","pubTime":"2024-07-03 22:16","pubTimestamp":1720016184,"startTime":"0","endTime":"0","summary":"北京时间2024年07月03日22时16分，Nkarta, Inc.股票出现波动，股价快速上涨5.13%。Nkarta, Inc.股票所在的生物技术行业中，整体跌幅为0.43%。其相关个股中，Cingulate Inc C/Wts 10/12/2026 、Cns Pharmaceuticals, Inc.、Effector Therapeutics Inc C/Wts 31/12/2025 涨幅较大，Cns Pharmaceuticals, Inc.、Annovis Bio, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为4979.31%、29.92%、10.54%，振幅较大的相关个股有Effector Therapeutics Inc C/Wts 31/12/2025 、Psyence Biomedical Ltd C/Wts 25/01/2029、Cns Pharmaceuticals, Inc.，振幅分别为500.00%、86.67%、70.57%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703221624941f3880&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703221624941f3880&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NKTX","BK4505"],"gpt_icon":0},{"id":"2448722162","title":"Nkarta, Inc.盘中异动 下午盘快速跳水5.13%报5.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448722162","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448722162?lang=zh_cn&edition=full","pubTime":"2024-07-03 01:17","pubTimestamp":1719940666,"startTime":"0","endTime":"0","summary":"北京时间2024年07月03日01时17分，Nkarta, Inc.股票出现异动，股价快速下挫5.13%。截至发稿，该股报5.55美元/股，成交量21.1865万股，换手率0.30%，振幅5.64%。Nkarta, Inc.股票所在的生物技术行业中，整体跌幅为1.14%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703011746941f32c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703011746941f32c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NKTX","BK4505"],"gpt_icon":0},{"id":"2446565867","title":"Nkarta, Inc.盘中异动 快速跳水5.03%报5.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446565867","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446565867?lang=zh_cn&edition=full","pubTime":"2024-06-28 01:19","pubTimestamp":1719508759,"startTime":"0","endTime":"0","summary":"北京时间2024年06月28日01时19分，Nkarta, Inc.股票出现异动，股价快速跳水5.03%。截至发稿，该股报5.67美元/股，成交量26.299万股，换手率0.37%，振幅6.87%。Nkarta, Inc.股票所在的生物技术行业中，整体跌幅为0.44%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。消息层面，截至01时19分，《H.C. Wainwright维持Nkarta买入评级，维持目标价23美元》资讯为影响Nkarta, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240628011919968178d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240628011919968178d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTX","BK4505","BK4139"],"gpt_icon":0},{"id":"2446039400","title":"Nkarta, Inc.盘中异动 早盘股价大跌5.06%报5.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446039400","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446039400?lang=zh_cn&edition=full","pubTime":"2024-06-26 22:41","pubTimestamp":1719412865,"startTime":"0","endTime":"0","summary":"北京时间2024年06月26日22时41分，Nkarta, Inc.股票出现波动，股价大幅下跌5.06%。截至发稿，该股报5.82美元/股，成交量17.8189万股，换手率0.25%，振幅4.73%。Nkarta, Inc.股票所在的生物技术行业中，整体跌幅为0.88%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626224106941f16ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626224106941f16ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTX","BK4139","BK4505"],"gpt_icon":0},{"id":"2446219248","title":"Nkarta, Inc.盘中异动 大幅上涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446219248","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446219248?lang=zh_cn&edition=full","pubTime":"2024-06-26 00:54","pubTimestamp":1719334489,"startTime":"0","endTime":"0","summary":"北京时间2024年06月26日00时54分，Nkarta, Inc.股票出现波动，股价急速上涨5.00%。Nkarta, Inc.股票所在的生物技术行业中，整体涨幅为1.81%。其相关个股中，Cns Pharmaceuticals, Inc.、Effector Therapeutics Inc C/Wts 31/12/2025 、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 涨幅较大，Cns Pharmaceuticals, Inc.、Effector Therapeutics, Inc.、Glycomimetics, Inc.较为活跃，换手率分别为868.24%、227.29%、175.81%，振幅较大的相关个股有Effector Therapeutics Inc C/Wts 31/12/2025 、Cns Pharmaceuticals, Inc.、Glycomimetics, Inc.，振幅分别为272.73%、77.13%、47.00%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626005449941f0f9b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626005449941f0f9b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","NKTX"],"gpt_icon":0},{"id":"2444595113","title":"Nkarta, Inc.盘中异动 大幅跳水5.16%报5.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2444595113","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444595113?lang=zh_cn&edition=full","pubTime":"2024-06-18 02:16","pubTimestamp":1718648166,"startTime":"0","endTime":"0","summary":"北京时间2024年06月18日02时16分，Nkarta, Inc.股票出现波动，股价快速跳水5.16%。截至发稿，该股报5.70美元/股，成交量22.5389万股，换手率0.32%，振幅5.66%。Nkarta, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061802160796814aeb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061802160796814aeb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTX","BK4505","BK4139"],"gpt_icon":0},{"id":"2442528215","title":"Nkarta, Inc.盘中异动 早盘急速拉升5.08%报6.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2442528215","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442528215?lang=zh_cn&edition=full","pubTime":"2024-06-12 21:31","pubTimestamp":1718199109,"startTime":"0","endTime":"0","summary":"北京时间2024年06月12日21时31分，Nkarta, Inc.股票出现波动，股价快速拉升5.08%。截至发稿，该股报6.83美元/股，成交量1.2417万股，换手率0.02%，振幅2.92%。Nkarta, Inc.股票所在的生物技术行业中，整体涨幅为0.34%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061221315096813b0d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061221315096813b0d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NKTX","BK4505"],"gpt_icon":0},{"id":"2441173277","title":"Nkarta, Inc.盘中异动 股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2441173277","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441173277?lang=zh_cn&edition=full","pubTime":"2024-06-05 22:47","pubTimestamp":1717598864,"startTime":"0","endTime":"0","summary":"北京时间2024年06月05日22时47分，Nkarta, Inc.股票出现波动，股价大幅拉升5.01%。Nkarta, Inc.股票所在的生物技术行业中，整体涨幅为0.78%。其相关个股中，Kineta, Inc.、诺瓦瓦克斯医药、Vir Biotechnology, Inc.涨幅较大，Cns Pharmaceuticals, Inc.、Adial Pharmaceuticals, Inc、诺瓦瓦克斯医药较为活跃，换手率分别为56.24%、48.15%、11.08%，振幅较大的相关个股有Kineta, Inc.、Biocardia Inc C/Wts 06/08/2024、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为63.28%、41.80%、30.30%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240605224744af8c2b59&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240605224744af8c2b59&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTX","BK4139","BK4505"],"gpt_icon":0},{"id":"2440496878","title":"Nkarta, Inc.盘中异动 大幅拉升5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2440496878","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440496878?lang=zh_cn&edition=full","pubTime":"2024-06-03 21:49","pubTimestamp":1717422562,"startTime":"0","endTime":"0","summary":"北京时间2024年06月03日21时49分，Nkarta, Inc.股票出现异动，股价大幅拉升5.01%。Nkarta, Inc.股票所在的生物技术行业中，整体涨幅为1.04%。其相关个股中，Surrozen Inc C/Wts 01/08/2031 、Biocardia Inc C/Wts 06/08/2024、Bio-Path Holdings, Inc.涨幅较大，Bio-Path Holdings, Inc.、Scorpius Holdings, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为2060.48%、53.70%、23.95%，振幅较大的相关个股有Bio-Path Holdings, Inc.、Scorpius Holdings, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为57.28%、26.85%、24.17%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240603214922aef30db3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240603214922aef30db3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTX","BK4139","BK4505"],"gpt_icon":0},{"id":"2439520604","title":"Nkarta, Inc.盘中异动 早盘股价大跌5.26%报6.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2439520604","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439520604?lang=zh_cn&edition=full","pubTime":"2024-05-29 21:33","pubTimestamp":1716989598,"startTime":"0","endTime":"0","summary":"北京时间2024年05月29日21时33分，Nkarta, Inc.股票出现波动，股价大幅跳水5.26%。截至发稿，该股报6.13美元/股，成交量1.7878万股，换手率0.03%，振幅2.16%。Nkarta, Inc.股票所在的生物技术行业中，整体跌幅为0.66%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240529213318af8aed9e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240529213318af8aed9e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NKTX","BK4505"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.nkartatx.com","stockEarnings":[{"period":"1week","weight":-0.0461},{"period":"1month","weight":0.1784},{"period":"3month","weight":-0.1481},{"period":"6month","weight":-0.1631},{"period":"1year","weight":1.9856},{"period":"ytd","weight":-0.0591}],"compareEarnings":[{"period":"1week","weight":-0.0196},{"period":"1month","weight":0.0009},{"period":"3month","weight":0.1087},{"period":"6month","weight":0.138},{"period":"1year","weight":0.2141},{"period":"ytd","weight":0.155}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Nkarta, Inc.于2015年7月在特拉华州成立。该公司是一家私人生物制药公司，致力于开发工程化的自然杀伤（NK）细胞来对抗癌症。该公司致力于利用NK细胞的天然强大功能来识别和杀死异常细胞，并募集适应性免疫效应子以产生特异性和持久性的反应。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.112423},{"month":2,"riseRate":0.5,"avgChangeRate":0.066988},{"month":3,"riseRate":0.25,"avgChangeRate":-0.082272},{"month":4,"riseRate":0.5,"avgChangeRate":0.150196},{"month":5,"riseRate":0.25,"avgChangeRate":-0.125785},{"month":6,"riseRate":0.25,"avgChangeRate":-0.12509},{"month":7,"riseRate":1,"avgChangeRate":0.048806},{"month":8,"riseRate":0.5,"avgChangeRate":-0.052154},{"month":9,"riseRate":0.25,"avgChangeRate":-0.049361},{"month":10,"riseRate":0.25,"avgChangeRate":-0.015611},{"month":11,"riseRate":0.75,"avgChangeRate":0.036387},{"month":12,"riseRate":0.5,"avgChangeRate":0.50486}],"exchange":"NASDAQ","name":"Nkarta","nameEN":"Nkarta"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Nkarta(NKTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Nkarta(NKTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Nkarta,NKTX,Nkarta股票,Nkarta股票老虎,Nkarta股票老虎国际,Nkarta行情,Nkarta股票行情,Nkarta股价,Nkarta股市,Nkarta股票价格,Nkarta股票交易,Nkarta股票购买,Nkarta股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Nkarta(NKTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Nkarta(NKTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}